EXCLUSIVE: Milestone Scientific Announces Medicare Price Assignment For CompuFlo Epidural System For Back Pain Covering Additional US States
Portfolio Pulse from Vandana Singh
Milestone Scientific Inc (NYSE:MLSS) announced that Novitas Solutions, Inc. has granted a Medicare Part B Physician payment rate for the CompuFlo Epidural System in additional US states. This decision covers two Medicare regions, Jurisdiction L and Jurisdiction H, and follows a similar assignment in Florida. The new pricing assignment is expected to significantly impact the market for the CompuFlo technology, which is designed to improve the accuracy and reduce the discomfort of epidural procedures.
July 23, 2024 | 12:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Milestone Scientific has secured Medicare Part B Physician payment rates for its CompuFlo Epidural System in additional states, covering Jurisdiction L and H. This follows a similar assignment in Florida and is expected to impact the $250M market for Medicare patients.
The Medicare pricing assignment for the CompuFlo Epidural System in additional states is a significant milestone for Milestone Scientific. This decision is expected to enhance the market reach and revenue potential of the CompuFlo technology, which addresses a substantial portion of the epidural steroid injection procedures in the US. The stock is currently trading lower, but the long-term impact of this regulatory approval is likely positive.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100